GE Healthcare expands European manufacturing site for sterile liquids

GE Healthcare has announced the expansion of its European manufacturing and distribution site for sterile liquids in Pasching, Austria.

The facility is set to be expanded to include production capability for large volumes of buffers, process liquids and cell culture media, while launching a rapid production service for prototype cell culture media and buffers.

This site serves biopharmaceutical companies in over 40 countries across Europe, Africa and the Middle East, helping to accelerate biomanufacturing processes. The aim of the refurbishment will be to bring it up to the same standard as the firm's Center of Excellence in Logan, Utah.

GE's additional production capacity at Pasching has been developed over two years, with an investment of $4.3 million (2.67 million pounds).

Dr David Radspinner, general manager of bioprocess cell culture at GE Healthcare's life sciences business, said: "Our aim is to accelerate development and scale-up for our biomanufacturing customers by providing simplified, flexible services both in Europe and in other regions."

The Pasching site also acts as a production and distribution centre for Europe, with more than 300,000 individual product items shipped through the location each year.